Search

Zai Lab Ltd ADR

Closed

SectorHealthcare

19.18 -2.19

Overview

Share price change

24h

Current

Min

19.13

Max

19.42

Key metrics

By Trading Economics

Income

-607K

-51M

Sales

-28M

100M

EPS

-0.46

Profit margin

-51.215

Employees

1,784

EBITDA

4.1M

-44M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+68.57% upside

Dividends

By Acuity

Next Earnings

6 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-67M

2.3B

Previous open

21.37

Previous close

19.18

News Sentiment

By Acuity

100%

0%

322 / 340 Healthcare

Zai Lab Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

24 Jul 2026, 23:51 UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

24 Jul 2026, 23:46 UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

24 Jul 2026, 23:41 UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

24 Jul 2026, 23:41 UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

24 Jul 2026, 23:41 UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

24 Jul 2026, 23:41 UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

24 Jul 2026, 23:36 UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

24 Jul 2026, 23:31 UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

24 Jul 2026, 23:21 UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

24 Jul 2026, 23:21 UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

24 Jul 2026, 23:21 UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

24 Jul 2026, 23:16 UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

24 Jul 2026, 23:16 UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

24 Jul 2026, 23:06 UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

24 Jul 2026, 23:01 UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

24 Jul 2026, 23:01 UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

24 Jul 2026, 23:01 UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

24 Jul 2026, 23:01 UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

24 Jul 2026, 23:01 UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

24 Jul 2026, 23:01 UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

24 Jul 2026, 22:22 UTC

News
Social Media

Uber shares are higher in after-market hours amid intensifying discussions about its partnership with Waymo and potential regulatory moves in the autonomous vehicle sector.

24 Jul 2026, 22:02 UTC

News

ServiceNow shares are lower in after-market trading despite reporting $4 billion in revenue and raising full-year subscription guidance amid ongoing sector concerns.

24 Jul 2026, 22:01 UTC

News
Social Media

Booz Allen Hamilton reported Q1 fiscal 2027 adjusted EPS of $1.81, exceeding expectations, and provided optimistic revenue guidance, boosting shares higher in after-market hours.

24 Jul 2026, 21:41 UTC

News

Tractor Supply Co shares are lower in after-market hours, continuing a decline amid broader market volatility linked to geopolitical tensions and oil supply concerns.

24 Jul 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

24 Jul 2026, 21:01 UTC

News

Golub Capital Bdc Inc reported a net asset value of $4.5 billion and is conducting a public offering of up to $10 billion in shares.

24 Jul 2026, 21:01 UTC

News

Hercules Capital Inc's shares are lower after the company closed a $325 million note offering, with proceeds for debt repayment and investments.

24 Jul 2026, 21:01 UTC

News

MetroCity Bankshares reported second-quarter net income of $22.1 million, missing expectations. Shares are higher in after-market trading, continuing a recent upward trend.

24 Jul 2026, 20:07 UTC

Social Media
Correlated Moves
News

iShares Core U.S. Aggregate Bond ETF is gaining as major indices rebound amid lower crude oil prices and inflation concerns. The ETF's yield is 4.99%.

24 Jul 2026, 20:07 UTC

News
Correlated Moves

Lovesac Co shares are lower as analysts express skepticism, citing slow revenue growth and weak free cash flow margins. The consensus price target is $24.17.

Peer Comparison

Price change

Zai Lab Ltd ADR Forecast

Price Target

By TipRanks

68.57% upside

12 Months Forecast

Average 32.4 USD  68.57%

High 44 USD

Low 21.6 USD

Based on 4 Wall Street analysts offering 12 month price targets forZai Lab Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Sentiment

By Acuity

322 / 340 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat